Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'neuroleptic' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1605 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McCall, WV
      Electroconvulsive thera in the era of modern psychopharmacology

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Segal, J; Isaacs, MD; Berk, M
      Neuroleptic malignant syndrome: Possible induction by olanzapine in a casewith relapsing catatonia

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    3. Agelink, MW; Zeit, T; Baumann, B; Majewski, T; Lemmer, W; Postert, T; Lukas, K; Klieser, E
      In vivo cardiovascular effects of the new atypical neuroleptic sertindole

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    4. Purdon, SE; Woodward, ND; Flor-Henry, P
      Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    5. Ananth, J; Burgoyne, KS; Gadasalli, R; Aquino, S
      How do the atypical antipsychotics work?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    6. Campbell, S; Stephens, S; Ballard, C
      Dementia with lewy bodies - Clinical features and treatment

      DRUGS & AGING
    7. Byerly, MJ; Weber, MT; Brooks, DL; Snow, LR; Worley, MA; Lescouflair, E
      Antipsychotic medications and the elderly - Effects on cognition and implications for use

      DRUGS & AGING
    8. Chanpattana, W; Chakrabhand, MLS
      Factors influencing treatment frequency of continuation ECT in schizophrenia

      JOURNAL OF ECT
    9. Malur, C; Francis, A
      Emergence of catatonia during ECT

      JOURNAL OF ECT
    10. Aziz, M; Maixner, DF; DeQuardo, J; Aldridge, A; Tandon, R
      ECT and mental retardation: A review and case reports

      JOURNAL OF ECT
    11. Malur, C; Pasol, E; Francis, A
      ECT for prolonged catatonia

      JOURNAL OF ECT
    12. Reeves, RR; Mack, JE; Torres, RA
      Neuroleptic malignant syndrome during a change from haloperidol to risperidone

      ANNALS OF PHARMACOTHERAPY
    13. Migneco, O; Benoit, M; Koulibaly, PM; Dygai, I; Bertogliati, C; Desvignes, P; Robert, PH; Malandain, G; Bussiere, F; Darcourt, J
      Perfusion brain SPECT and statistical parametric mapping analysis indicatethat apathy is a cingulate syndrome: A study in Alzheimer's disease and nondemented patients

      NEUROIMAGE
    14. Maclean, LE; Collins, CC; Byrne, EJ
      Dementia with Lewy bodies treated with rivastigmine: Effects on cognition,neuropsychiatric symptoms, and sleep

      INTERNATIONAL PSYCHOGERIATRICS
    15. Erbagci, AB; Herken, H; Koyluoglu, O; Yilmaz, N; Tarakcioglu, M
      Serum IL-1 beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

      MEDIATORS OF INFLAMMATION
    16. Krebs, S; Dormann, H; Muth-Selbach, U; Hahn, EG; Brune, K; Schneider, HT
      Risperidone-induced cholestatic hepatitis

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    17. Ovalle, S; Zamanillo, D; Andreu, F; Farre, AJ; Guitart, X
      Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic

      EUROPEAN JOURNAL OF NEUROSCIENCE
    18. Barnes, TRE; Joyce, EM
      Antipsychotic drug treatment: recent advances

      CURRENT OPINION IN PSYCHIATRY
    19. Riehemann, S; Volz, HP; Stutzer, P; Smesny, S; Gaser, C; Sauer, H
      Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test - a fMRI study

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    20. Wiedemann, G; Hahlweg, K; Muller, U; Feinstein, E; Hank, G; Dose, M
      Effectiveness of targeted intervention and maintenance pharmacotherapy in conjunction with family intervention in schizophrenia

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    21. Chen, EYH; Lam, LCW; Chen, RYL; Nguyen, DGH; Kwok, CL; Au, JWY
      Neurological signs and sustained attention impairment in schizophrenia

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    22. Lo, D; Hilbush, B; Sutcliffe, JG
      TOGA analysis of gene expression to accelerate target development

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    23. Shiloh, R; Weizman, A; Epstein, Y; Rosenberg, SL; Valevski, A; Dorfman-Etrog, P; Wiezer, N; Katz, N; Munitz, H; Hermesh, H
      Abnormal thermoregulation in drug-free male schizophrenia patients

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    24. Hermesh, H; Manor, I; Shiloh, R; Weizman, R; Munitz, H
      Absence of myoglobinuria in acute psychotic patients with marked elevationin serum creatine phosphokinase level

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    25. Rubia, K; Russell, T; Bullmore, ET; Soni, W; Brammer, MJ; Simmons, A; Taylor, E; Andrew, C; Giampietro, V; Sharma, T
      An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function

      SCHIZOPHRENIA RESEARCH
    26. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
      Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    27. Turenne, SD; Seeman, M; Ross, BM
      An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response

      SCHIZOPHRENIA RESEARCH
    28. Webster, MJ; Weickert, CS; Herman, MM; Hyde, TM; Kleinman, JE
      Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia

      SCHIZOPHRENIA RESEARCH
    29. Purdon, SE; Labelle, A; Boulay, L
      Neuropsychological change in schizophrenia after 6 weeks of clozapine

      SCHIZOPHRENIA RESEARCH
    30. Martin, BC; Miller, LS; Kotzan, JA
      Antipsychotic prescription use and costs for persons with schizophrenia inthe 1990s: current trends and five year time series forecasts

      SCHIZOPHRENIA RESEARCH
    31. Kohler, CG; Moberg, PJ; Gur, RE; O'Connor, MJ; Sperling, MR; Doty, RL
      Olfactory dysfunction in schizophrenia and temporal lobe epilepsy

      NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY
    32. Voruganti, L; Slomka, P; Zabel, P; Costa, G; So, A; Mattar, A; Awad, AG
      Subjective effects of AMPT-induced dopamine depletion in schizophrenia: Correlation between dysphoric responses and striatal D-2 binding ratios on SPECT imaging

      NEUROPSYCHOPHARMACOLOGY
    33. Scheepers, FE; de Wied, CCG; Pol, HEH; van de Flier, W; van der Linden, JA; Kahn, RS
      The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics

      NEUROPSYCHOPHARMACOLOGY
    34. Malone, RP; Cater, J; Sheikh, RM; Choudhury, MS; Delaney, MA
      Olanzapine versus haloperidol in children with autistic disorder: An open pilot study

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    35. Eastwood, SL; Burnet, PWJ; Gittins, R; Baker, K; Harrison, PJ
      Expression of serotonin 5-HT2A receptors in the human cerebellum and alterations in schizophrenia

      SYNAPSE
    36. Rodriguez, JJ; Garcia, DR; Nakabeppu, Y; Pickel, VM
      FosB in rat striatum: Normal regional distribution and enhanced expressionafter 6-month haloperidol administration

      SYNAPSE
    37. Grimm, JW; Chapman, MA; Zahm, DS; See, RE
      Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats

      SYNAPSE
    38. Dawson, NM; Hamid, EH; Egan, MF; Meredith, GE
      Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment

      SYNAPSE
    39. Morgenstern, H; Glazer, WM; Woods, SW
      Risperidone and tardive dyskinesia

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    40. Simard, M; van Reekum, R
      Dementia with lewy bodies in Down's syndrome

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    41. Hansen, L
      A critical review of akathisia, and its possible association with suicidalbehaviour

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    42. Arnaout, MS; Antun, FP; Ashkar, K
      Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    43. Kiser, RS; Cohen, HW; Freedenfeld, RN; Jewell, C; Fuchs, PN
      Olanzapine for the treatment of fibromyalgia symptoms

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    44. Muqit, MMK; Rakshi, JS; Shakir, RA; Larner, AJ
      Catatonia or abulia? A difficult differential diagnosis

      MOVEMENT DISORDERS
    45. Kalant, H
      The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    46. Jacobs, ES; Dickstein, DP; Liebelt, EL
      Novel psychotropic medications in children: New toxicities to master

      PEDIATRIC EMERGENCY CARE
    47. Angelini, G; Ketzler, JT; Coursin, DB
      Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit

      CRITICAL CARE CLINICS
    48. Burns, MJ
      The pharmacology and toxicology of atypical antipsychotic agents

      JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
    49. Schmitt, A; Maras, A; Braus, DF; Petroianu, G; Jatzko, A; Gattaz, WF
      Antipsychotics and phospholipid metabolism in schizophrenia

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    50. Baptista, T; Lacruz, A; Meza, T; Contreras, Q; Delgado, C; Mejias, MA; Hernandez, L
      Antipsychotic drugs and obesity: Is prolactin involved?

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    51. Parker, V; Remington, G
      Electroconvulsive therapy in cases of treatment-resistant psychosis

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    52. Labelle, A; Light, M; Dunbar, F
      Risperidone treatment of outpatients with schizophrenia: No evidence of sex differences in treatment response

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    53. Zahn, TP; Pickar, D; van Kammen, DP
      Neuroleptic effects on autonomic activity in schizophrenia: Between-group and within-subject paradigms and comparisons with controls

      SCHIZOPHRENIA BULLETIN
    54. Johnson-Selfridge, M; Zalewski, C
      Moderator variables of executive functioning in schizophrenia: Meta-analytic findings

      SCHIZOPHRENIA BULLETIN
    55. Tattan, TMG; Creed, FH
      Negative symptoms of schizophrenia and compliance with medication

      SCHIZOPHRENIA BULLETIN
    56. Kubo, S; Orihara, Y; Kitamura, O; Ikematsu, K; Tsuda, R; Nakasono, I
      An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria

      FORENSIC SCIENCE INTERNATIONAL
    57. Valevski, A; Loebl, T; Keren, T; Bodinger, L; Weizman, A
      Response of catatonia to risperidone: Two case reports

      CLINICAL NEUROPHARMACOLOGY
    58. Orr, G; Munitz, H; Hermesh, H
      Low-dose clozapine for the treatment of Parkinson's disease in a patient with schizophrenia

      CLINICAL NEUROPHARMACOLOGY
    59. Meador-Woodruff, JH; Hogg, AJ; Smith, RE
      Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder

      BRAIN RESEARCH BULLETIN
    60. Schwarz, MJ; Muller, N; Riedel, M; Ackenheil, M
      The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms

      MEDICAL HYPOTHESES
    61. Kilian, R; Holzinger, A; Angermeyer, MC
      "It may be somewhat more demanding sometimes, but also more interesting". Psychiatrists evaluate the impact of psychoeducation on outpatient treatment of schizophrenia

      PSYCHIATRISCHE PRAXIS
    62. Fink, M
      Catatonia: syndrome or schizophrenia subtype? Recognition and treatment

      JOURNAL OF NEURAL TRANSMISSION
    63. Hassin-Baer, S; Sirota, P; Korczyn, AD; Treves, TA; Epstein, B; Shabtai, H; Martin, T; Litvinjuk, Y; Giladi, N
      Clinical characteristics of neuroleptic-induced parkinsonism

      JOURNAL OF NEURAL TRANSMISSION
    64. Teter, CJ; Guthrie, SK
      A comprehensive review of MDMA and GHB: Two common club drugs

      PHARMACOTHERAPY
    65. Sethi, KD
      Movement disorders induced by dopamine blocking agents

      SEMINARS IN NEUROLOGY
    66. Turner, MR; Gainsborough, N
      Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen

      JOURNAL OF PSYCHOPHARMACOLOGY
    67. Wappler, F
      Malignant hyperthermia

      EUROPEAN JOURNAL OF ANAESTHESIOLOGY
    68. O'Reilly, RL; Lane, A; Cernovsky, ZZ; O'Callaghan, E
      Neurological soft signs, minor physical anomalies and handedness in schizophrenia

      EUROPEAN JOURNAL OF PSYCHIATRY
    69. Garcia-Anaya, M; Apiquian, R; Fresan, A
      Atypical anti-psychotics: review article.

      SALUD MENTAL
    70. Gareri, P; Cotroneo, A; Marchisio, U; Curcio, M; De Sarro, G
      Risperidone in the treatment of behavioral disorders in elderly patients with dementia

      ARCHIVES OF GERONTOLOGY AND GERIATRICS
    71. Lee, JH; Woo, JI; Meltzer, HY
      Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia

      PSYCHIATRY RESEARCH
    72. Karoumi, B; Saoud, M; d'Amato, T; Rosenfeld, F; Denise, P; Gutknecht, C; Gaveau, V; Beaulieu, FE; Dalery, J; Rochet, T
      Poor performance in smooth pursuit and antisaccadic eye-movement tasks in healthy siblings of patients with schizophrenia

      PSYCHIATRY RESEARCH
    73. Tohen, M; Zhang, F; Taylor, CC; Burns, P; Zarate, C; Sanger, T; Tollefson, G
      A meta-analysis of the use of typical antipsychotic agents in bipolar disorder

      JOURNAL OF AFFECTIVE DISORDERS
    74. Rhoney, DH; Parker, D
      Use of sedative and analgesic agents in neurotrauma patients: Effects on cerebral physiology

      NEUROLOGICAL RESEARCH
    75. Catafau, AM
      Brain SPECT in clinical practice. Part 1: Perfusion

      JOURNAL OF NUCLEAR MEDICINE
    76. Chelben, J; Strous, RD; Lustig, M; Baruch, Y
      Remission of SSRI-induced akathisia after switch to nefazodone

      JOURNAL OF CLINICAL PSYCHIATRY
    77. Compton, MT; Miller, AH
      Priapism associated with conventional and atypical antipsychotic medications: A review

      JOURNAL OF CLINICAL PSYCHIATRY
    78. Ballard, CG; O'Brien, JT; Swann, AG; Thompson, P; Neill, D; McKeith, IG
      The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: Persistence and new cases over 1 year of follow-up

      JOURNAL OF CLINICAL PSYCHIATRY
    79. Hori, H; Ohmori, O; Shinkai, T; Kojima, H; Nakamura, J
      Association between three functional polymorphisms of dopamine D2 receptorgene and tardive dyskinesia in schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    80. Schulze, TG; Schumacher, J; Muller, DJ; Krauss, H; Alfter, D; Maroldt, A; Ahle, G; Maroldt, AO; Fernandez, ANY; Weber, T; Held, T; Propping, P; Maier, W; Nothen, MM; Rietschel, M
      Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and Tardive dyskinesia in schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    81. Cohen, MM
      Frog decline, frog malformations, and a comparison of frog and human health

      AMERICAN JOURNAL OF MEDICAL GENETICS
    82. Hodge, CH; Jewell, M; Gummin, DD; Leikin, JB
      Atypical presentation of risperidone toxicity

      VETERINARY AND HUMAN TOXICOLOGY
    83. Santi, AN; Parker, LA
      The dopamine antagonist, alpha-flupenthixol, interferes with naloxone-induced place aversion learning, but not with acute opiate dependence in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    84. Wadenberg, MLG; Browning, JL; Young, KA; Hicks, PB
      Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    85. Silva, MRP; Bernardi, MM; Felicio, LF
      Effects of dopamine receptor antagonists on ongoing maternal behavior in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    86. Gracious, BL; Findling, RL
      Antipsychotic medications for children and adolescents

      PEDIATRIC ANNALS
    87. Nelson, DE
      Akathisia - A brief review

      SCOTTISH MEDICAL JOURNAL
    88. Norman, RMG; Malla, AK
      Duration of untreated psychosis: a critical examination of the concept andits importance

      PSYCHOLOGICAL MEDICINE
    89. Susman, VL
      Clinical management of neuroleptic malignant syndrome

      PSYCHIATRIC QUARTERLY
    90. Libenson, MH; Lev, MH; Yang, JM; Mark, EJ
      A 16-year-old boy with an altered mental status and muscle rigidity. Strychnine poisoning. Bipolar disease.

      NEW ENGLAND JOURNAL OF MEDICINE
    91. Wood, MD; Reavill, C; Trail, B; Wilson, A; Stean, T; Kennett, GA; Lightowler, S; Blackburn, TP; Thomas, D; Gager, TL; Riley, G; Holland, V; Bromidge, SM; Forbes, IT; Middlemiss, DN
      SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

      NEUROPHARMACOLOGY
    92. Frey, R; Schreinzer, D; Heiden, A; Kasper, S
      Electroconvulsive therapie

      NERVENARZT
    93. Elazar, Z; Berchanski, A
      Glutamatergic-cholinergic synergistic interaction in the pontine reticularformation. Effects on catalepsy

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    94. Kulkarni, SK; Naidu, PS
      Tardive dyskinesia: An update

      DRUGS OF TODAY
    95. Sutor, B; Rummans, TA; Smith, GE
      Assessment and management of behavioral disturbances in nursing home patients with dementia

      MAYO CLINIC PROCEEDINGS
    96. Dean, B; Hussain, T; Scarr, E; Pavey, G; Copolov, DL
      Extended treatment with typical and atypical antipsychotic drugs - Differential effects on the densities of dopamine D-2-like and GABA(A) receptors in rat striatum

      LIFE SCIENCES
    97. Thune, JJ; Uylings, HBM; Pakkenberg, B
      No deficit in total number of neurons in the prefrontal cortex in schizophrenics

      JOURNAL OF PSYCHIATRIC RESEARCH
    98. Ellenbroek, BA; Liegeois, JF; Bruhwyler, J; Cools, AR
      Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    99. Ueda, M; Hamamoto, M; Nagayama, H; Okubo, S; Amemiya, S; Katayama, Y
      Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    100. Goff, ML
      Protecting our mentally ill: A critique of the role of Indiana state courts in protecting involuntarily committed mental patients' right to refuse medication

      INDIANA LAW JOURNAL


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 00:20:50